Catalog No.
YVV25301
Expression system
E. coli
Species
Dengue virus type 1 (strain Nauru/West Pac/1974) (DENV-1)
Protein length
Gly122-Arg205
Predicted molecular weight
37.70 kDa
Nature
Recombinant
Endotoxin level
Please contact with the lab for this information.
Purity
>90% as determined by SDS-PAGE.
Accession
P17763
Applications
ELISA, Immunogen, SDS-PAGE, WB, Bioactivity testing in progress
Form
Lyophilized
Storage buffer
Lyophilized from a solution in PBS pH 7.4, 0.02% NLS, 1mM EDTA, 4% Trehalose, 1% Mannitol.
Reconstitution
Reconstitute in sterile water for a stock solution. A copy of datasheet will be provided with the products, please refer to it for details.
Shipping
In general, proteins are provided as lyophilized powder/frozen liquid. They are shipped out with dry ice/blue ice unless customers require otherwise.
Stability and Storage
Use a manual defrost freezer and avoid repeated freeze thaw cycles. Store at 2 to 8°C for frequent use. Store at -20 to -80°C for twelve months from the date of receipt.
Alternative Names
Genome polyprotein, Protein prM, Precursor membrane protein
Seroprevalence and Placental Transfer of Zika and Dengue Virus Antibodies in Postpartum Women in Southeast Brazil., PMID:40400258
Spatiotemporal dispersion of DENV-1 genotype V in Western Colombia., PMID:40395613
Characterization of serotype-specific Dengue virus T cell inhibition., PMID:40336275
Quantifying temporal differences in the induction of interferon-mediated signalling observed in a dengue virus 1 human infection model: insights from longitudinal proteome analysis., PMID:40288237
Identification of Potential Inhibitors Targeting Non-Structural Proteins NS3 and NS5 of Dengue Virus Using Docking and Deep Learning Approaches., PMID:40284001
Ultrasensitive Peptide-Based Electrochemical Biosensor for Universal Diagnostic of Dengue., PMID:40277549
Integrated serological surveillance for neglected tropical diseases, vaccine-preventable diseases, and arboviruses in Samoa, 2018., PMID:40221582
The epidemiology and identification of risk factors associated with severe dengue during the 2023 dengue outbreak in Kaohsiung City, Taiwan., PMID:40220842
Chronic Dengue Virus Encephalitis: A Case Study and Metagenomic Analysis., PMID:40215446
Seropositivity to Dengue, Zika, Yellow Fever, and West Nile Viruses in Senegal, West Africa., PMID:40207881
Characterization of dengue patients in Vietnam: Clinical, virological, and IL-10 profiles during 2021- 2022 outbreaks., PMID:40153381
Epidemiological and molecular typing of dengue viruses circulating in Jorhat district, Assam, India., PMID:40132676
A one-pot method for universal Dengue virus detection by combining RT-RPA amplification and CRISPR/Cas12a assay., PMID:40128655
Prevalence and Circulating Serotypes of Dengue in Bastar, Chhattisgarh: A Cross-Sectional Study., PMID:40123828
Advancements in dengue vaccines: A historical overview and pro-spects for following next-generation candidates., PMID:40044132
Dengue dynamics in Bali: Serotype shifts, genotype replacement and multiple virus lineage circulation in the last 10 years., PMID:40008453
miRNome analysis reveals mir-155-5p as a protective factor to dengue infection in a resistant Thai cohort., PMID:39976655
Investigation of severe dengue outbreak in Maumere, East Nusa Tenggara, Indonesia: Clinical, serological, and virological features., PMID:39965014
RT-RPA Assisted CRISPR/Cas12a Based One-Pot Rapid and Visual Detection of the Pan-Dengue Virus., PMID:39949262
Conventional and antibody-enhanced DENV infection of human macrophages induces differential immunotranscriptomic profiles., PMID:39902963
Comparison of clinical and virological features in pediatric and adult dengue cases at Insein General Hospital during Myanmar's 2022 dengue season., PMID:39881372
Achievements and Approaches in the Search for Small-Molecule Dengue NS2B/NS3 Inhibitors., PMID:39871573
Identification of Dengue virus serotype and genotype: A comprehensive study from AIIMS Patna, Bihar., PMID:39848407
Simultaneous detection of dengue virus serotypes in a dual-serotype-detection nucleic acid based lateral flow assay., PMID:39798241
The Compound AT13148 Targeting AKT Suppresses Dengue Virus 2 Replication., PMID:39772930
The 2023 dengue outbreak in Lombardy, Italy: A one-health perspective., PMID:39755224
Clinical characteristics of dengue virus infections in Karachi from 2019 to 2023: a cross-sectional study., PMID:39738341
Trends in dengue virus positivity & serotyping in Rajasthan., PMID:39737514
Genetic diversity of dengue virus circulating in the Philippines (2014-2019) and comparison with dengue vaccine strains., PMID:39700304
All-Atom Perspective of the DENV-3 Methyltransferase Inhibition Mechanism., PMID:39639592
Serotype-Specific Dengue Virus IgG Assay Using EDIII-Based Recombinant Proteins and Its Application in an Endemic Population in Northeast Brazil., PMID:39620308
Dominance of dengue virus serotype-2 in Pakistan (2023-2024): Molecular characterization of the envelope gene and exploration of antiviral targets., PMID:39557198
Genetic and structural characterization of dengue virus involved in the 2023 autochthonous outbreaks in central Italy., PMID:39475407
Computational identification of Vernonia cinerea-derived phytochemicals as potential inhibitors of nonstructural protein 1 (NSP1) in dengue virus serotype-2., PMID:39474614
Long term T cell response and safety of a tetravalent dengue vaccine in healthy children., PMID:39420169
Dengue fever as autochthonous infectious disease in Italy: Epidemiological, clinical and virological characteristics., PMID:39306188
Envelope domain III E324, E351, and E380 mutations lever adaptive evolution of DENV-1 genotype I., PMID:39230303
Commercial Enzyme-Linked Immunosorbent Assay Kit Is Useful for Detection of Recombinant and Secretory Nonstructural-1 Protein Antigen of Dengue Virus., PMID:39134458
Efficacy and safety of Butantan-DV in participants aged 2-59 years through an extended follow-up: results from a double-blind, randomised, placebo-controlled, phase 3, multicentre trial in Brazil., PMID:39116904
Predominance of DENV-3 among patients in Ouagadougou, Burkina Faso., PMID:39113365
Impact of pre-existing cross-reactive antibodies on cyclic dengue outbreaks in the hyperendemic region of Bali, Indonesia., PMID:39089369
Machine-learning-assisted high-throughput identification of potent and stable neutralizing antibodies against all four dengue virus serotypes., PMID:39060292
Diagnostic accuracy of Dengue NS1 lateral flow immunoassay in comparison to reverse transcriptase polymerase chain reaction and enzyme linked Immunosorbent Assay., PMID:38942174
Identifying Key Drivers of Efficient B Cell Responses: On the Role of T Help, Antigen-Organization, and Toll-like Receptor Stimulation for Generating a Neutralizing Anti-Dengue Virus Response., PMID:38932390
Distinct inflammatory markers in primary and secondary dengue infection: can cytokines CXCL5, CXCL9, and CCL17 act as surrogate markers?, PMID:38884301
C1q modulation of antibody-dependent enhancement of dengue virus infection in human myeloid cell lines is dependent on cell type and antibody specificity., PMID:38880233
Dengue Virus and Zika Virus Seroprevalence in the South Pacific Populations of the Cook Islands and Vanuatu., PMID:38793688
Development of optical and electrochemical immunodevices for dengue virus detection., PMID:38780022
Genotype of dengue virus serotype 1 in relation to severe dengue in Guangzhou, China., PMID:38682660
Circulating serotypes and genotypes of dengue virus in North India: An observational study., PMID:38648413
For research use only. Not for human or drug use.
